carcinoid tumor
Showing 1 - 25 of 30
Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +18 more
- Clinical Encounter
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jul 24, 2023
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Carcinoid Syndrome, Carcinoid, Carcinoid Tumor Trial in Newport Beach, Lexington, Stony Brook (Randomized: 40 mg Paltusotine,
Recruiting
- Carcinoid Syndrome
- +8 more
- Randomized: 40 mg Paltusotine
- Randomized: 80 mg Paltusotine
-
Newport Beach, California
- +5 more
Jan 3, 2023
Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,
Active, not recruiting
- Carcinoid Tumor
- +2 more
- Laboratory Biomarker Analysis
- +3 more
-
Buffalo, New York
- +1 more
Nov 8, 2022
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester
Not yet recruiting
- Neuroendocrine Tumors
- +8 more
-
Iowa City, Iowa
- +1 more
Nov 23, 2022
Carcinoid Tumor Trial in Boston (Ziv-aflibercept)
Active, not recruiting
- Carcinoid Tumor
-
Boston, Massachusetts
- +2 more
Oct 14, 2022
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)
Not yet recruiting
- Neuroendocrine Tumors
- +6 more
-
Vancouver, British Columbia, CanadaBC Cancer
Aug 19, 2022
Atypical Carcinoid Tumor, Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor Trial in United States (Cabozantinib
Recruiting
- Atypical Carcinoid Tumor
- +18 more
- Cabozantinib S-malate
- +3 more
-
Anchorage, Alaska
- +425 more
Aug 12, 2022
Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)
Active, not recruiting
- Carcinoid Tumor
- Pancreatic Neuroendocrine Tumor
-
Boston, Massachusetts
- +1 more
Jul 15, 2022
Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)
Recruiting
- Carcinoid Tumor
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 14, 2022
Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)
Recruiting
- Carcinoid Syndrome
- +3 more
- Dual-Energy Computed Tomography
-
Houston, TexasM D Anderson Cancer Center
Jul 28, 2021
Dynamic Whole Body Positron Emission Tomography/Computed
Recruiting
- Neuroendocrine Tumors
- +5 more
- 18F-FDG PET/CT
- +2 more
-
Vancouver, British Columbia, CanadaBC Cancer
Jan 25, 2021
Neuroendocrine Tumors, Carcinoid Tumor, Carcinoma, Neuroendocrine Trial in Quebec City (177Lu-Octreotate)
Recruiting
- Neuroendocrine Tumors
- +2 more
-
Quebec City, Quebec, CanadaCHU de Québec - Université Laval
Jul 15, 2020
SwissNET - a Registry for Neuroendocrine Tumours in Switzerland
Recruiting
- Neuroendocrine Tumors
- Carcinoid Tumor
-
Aarau, Switzerland
- +54 more
Jan 20, 2020
Endoscopic Treatment of Bronchial Carcinoid Tumors
Completed
- Carcinoid Tumor
- Medical data collection
-
Saint-Étienne, FranceCHU de Saint-Etienne
Oct 26, 2018
Carcinoid Tumor, Malignant Carcinoid Syndrome Trial in Worldwide (Octreotide, Placebo, Everolimus)
Completed
- Carcinoid Tumor
- Malignant Carcinoid Syndrome
- Octreotide
- +2 more
-
Tucson, Arizona
- +69 more
Nov 11, 2014
Neuroendocrine, Neuroendocrine Tumor, Neuroendocrine Cancer Trial in Kenner (68Ga-DOTATATE will be given in tracer doses and
Unknown status
- Neuroendocrine
- +7 more
- 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography.
-
Kenner, LouisianaOchsner Medical Center - Kenner
Jan 16, 2014